Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Necchi A, Raggi D, Giannatempo P, Alessi A, et al. Exceptional response to olaparib in BRCA2-altered urothelial carcinoma after PD-L1 inhibitor and chemotherapy failure. Eur J Cancer 2018;96:128-130.
PMID: 29680362


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016